Is it safe to take hydroxyzine and citalopram together?

Can Hydroxyzine and Citalopram Be Taken Together?

Yes, hydroxyzine and citalopram can be taken together, but this combination requires careful monitoring due to additive QT prolongation risk—both drugs independently prolong the QT interval and can increase the risk of potentially fatal cardiac arrhythmias (torsade de pointes). This combination should only be used when clinically necessary and with appropriate cardiac risk assessment.

Key Safety Concerns

QT Prolongation Risk - The Primary Issue

Both medications carry documented risks of QT prolongation:

• Citalopram is classified as having the highest risk among SSRIs for QT prolongation, with FDA/EMA-mandated dose restrictions (maximum 40 mg daily, reduced to 20 mg in patients >60 years) 12
• Hydroxyzine causes QT prolongation with documented cases of torsade de pointes, particularly in patients with other risk factors 34

The FDA label for hydroxyzine explicitly warns: "Caution is recommended during the concomitant use of drugs known to prolong the QT interval" and specifically lists "certain antidepressants (e.g., citalopram, fluoxetine)" as concerning combinations 3.

Risk Stratification Algorithm

Before prescribing this combination, assess:

1. Baseline QTc interval - Obtain ECG if:

   • Patient >60 years old
   • Pre-existing cardiac disease
   • Electrolyte abnormalities present
   • Already on other QT-prolonging medications
   • Family history of long QT syndrome

2. Additional risk factors:

   • Female sex (higher arrhythmia risk) 2
   • Hypokalemia or hypomagnesemia
   • Bradycardia or heart failure
   • Recent myocardial infarction
   • Renal impairment (affects drug clearance)

3. Medication factors:

   • Citalopram dose (keep ≤20 mg if >60 years, ≤40 mg if younger) 1
   • Hydroxyzine dose (use lowest effective dose)

Clinical Management Strategy

If You Decide to Use This Combination:

Monitoring requirements:

• Baseline ECG before starting combination
• Stop immediately if QTc >500 ms or increases >60-70 ms from baseline 22
• Monitor electrolytes (potassium, magnesium) regularly, especially if patient on diuretics
• Recheck ECG after dose changes or if new symptoms develop

Safer alternatives to consider first:

Instead of citalopram, consider SSRIs with negligible QT risk 22:

• Sertraline (preferred - lowest overdose risk when combined with other medications) 5
• Paroxetine (minimal QT effects)

These alternatives maintain antidepressant efficacy while substantially reducing cardiac risk when combined with hydroxyzine.

Important Clinical Pitfalls

Common mistake: Assuming all SSRIs are equivalent for cardiac safety. The 2023 Canadian guidelines emphasize that within-class differences are substantial—citalopram and escitalopram carry the highest SSRI risk, while sertraline and paroxetine are negligible 22.

Elderly patients: The combination is particularly risky in patients >60 years, who have both higher baseline QT prolongation risk and are more susceptible to sedation and confusion from hydroxyzine 3. Consider dose reduction or alternative agents.

Drug accumulation: Both medications can accumulate in renal impairment—adjust doses accordingly and monitor more frequently 2.

Bottom Line Recommendation

While this combination is not absolutely contraindicated, it should be avoided when possible. If both medications are clinically necessary:

1. Use the lowest effective doses
2. Obtain baseline ECG and monitor QTc
3. Check and correct electrolytes
4. Educate patient about warning symptoms (palpitations, syncope, dizziness)
5. Strongly consider switching citalopram to sertraline or paroxetine to reduce cardiac risk while maintaining therapeutic benefit

The evidence consistently shows that safer alternatives exist that don't compromise efficacy 2225.